Jean-Luc Girardet

Mailchimp Mandrill Outlook Google Cloud Hosting WP Engine Salesforce WordPress.org Google Analytics Mobile Friendly reCAPTCHA Google Tag Manager Typekit Nginx BugHerd Remote AI

biotechnology: pharmaceutical preparations health care pharmaceutical manufacturing rare diseases alagille syndrome progressive familial intrahepatic cholestasis livmarli maralixibat ibat inhibitor cholestasis bile acid synthesis disorders chenodal chenodeoxycholic acid clinical trials genetic neurology cerebrotendinous xanthomatosis primary sclerosing cholangitis primary biliary cholangitis diagnostic testing program investigational therapies patient stories medical affairs therapeutic areas pruritus liver disease treatment options metabolism disorders cholesterol metabolism patient-centered approach transformative therapies biopharmaceuticals evidence-based medicine unmet medical need medical advancements patient access programs biologics orphan drug designation therapeutic development clinical evaluations fda approval breakthrough therapy designation scientific research data-driven insights patient advocacy healthcare professionals personalized medicine medical compliance life sciences ethical standards healthcare consulting rare metabolic diseases integrated care model therapeutic innovations liver diseases innovative therapies patient-centric cholestatic pruritus metabolic disorders drug development clinical research healthcare providers insurance payers patient engagement unmet medical needs genetic disorders commercializing therapies healthcare innovation rare disease therapeutics patient access specialized treatments healthcare education pharmaceutical industry biotechnology quality of life healthcare collaboration market segmentation competitive landscape health wellness & fitness pharmaceuticals medical hospital & health care